Home / Apomorphine / Canada
CA ATC N04BC07 · updated 2 Nov 2026
Apomorphine shortage in Canada
Is there an Apomorphine shortage in Canada?
Yes. As of 2 Nov 2026, 2 Apomorphine products are reported short in Canada, the first since 1 Oct 2023. No return date has been given. Main reason: manufacturing problem.
Also short in Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MOVAPO (30MG/3ML PRE-FILLED PEN) | PALADIN LABS INC. | 1 Oct 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MOVAPO (5x 3mL) discontinuation | PALADIN LABS INC. | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.